Skip to main content
Clinical Experience With an L-Proline-Stabilized 10 % Intravenous Immunoglobulin (Privigen®): Real-Life Effectiveness and Tolerability
Published Web Location
http://europepmc.org/articles/PMC4165870?pdf=renderNo data is associated with this publication.
Abstract
Purpose This retrospective study evaluated the effectiveness and tolerability in clinical practice of an L-proline-stabilized 10 % intravenous immunoglobulin (IVIG; Privigen®) in patients with primary (PID) or secondary immunodeficiency (SID). Methods Pati
Many UC-authored scholarly publications are freely available on this site because of the UC's open access policies. Let us know how this access is important for you.